Abstract. Acute ischemic stroke is a significant cause of high morbidity and mortality in the aging population globally. However, current therapeutic strategies for acute ischemic stroke are limited. Atherosclerotic plaque is considered an independent risk factor for acute ischemic stroke. To identify biomarkers for carotid atheromatous plaque, bioinformatics analysis of the gene microarray data of plaque and intact tissue from individuals was performed. Differentially expressed genes (DEGs) were identified using the Multtest and Limma packages of R language, including 56 downregulated and 69 upregulated DEGs. Enriched microRNA (miRNA or miR) DEGs networks were generated using WebGestalt software and the STRING databases, and the miRNAs were validated using serum from acute ischemic stroke patients with reverse transcription quantitative PCR (RT-qPCR). Four confirmed differentially expressed miRNAs (miR-9, -22, -23 and -125) were associated with 28 upregulated DEGs, and 7 miRNAs (miR-9, -30, -33, -124, -181, -218 and -330) were associated with 25 downregulated DEGs. Gene ontology (GO) function suggested that the confirmed miRNA-targeted DEGs predominately associated with signal transduction, the circulatory system, biological adhesion, striated muscle contraction, wound healing and the immune system. The confirmed miRNA-targeted genes identified serve as potential therapeutic targets for acute ischemic stroke.
Introduction
Stroke is one of the most common causes of mortality and disability worldwide (1) (2) (3) . Stroke is a clinical syndrome with pathological types including ischemic, intracerebral hemorrhage, and sub-arachnoid hemorrhage types (4, 5) . Stroke risk increases with age (6) . Ischemic stroke, which accounts for 87% of all stroke subtypes presented clinically (7) , is prevalent in populations of European origin and Chinese populations (5, 8, 9) . Acute ischemic stroke is the major cause of high morbidity and mortality in the aging population worldwide (10) . The prognosis is worse for stroke, with up to 50% of the individuals worldwide confirmed to have suffered a stroke succumbing or being dependent on carers 6 months after the event (5) . Current therapeutic strategies for acute ischemic stroke are limited (3) . Intravenous thrombolysis with aspirin improves the outcome for only a small proportion of patients presenting early after symptom onset with acute ischemic stroke (11) . Thus, seeking clinical diagnosis, prognostic biomarkers and therapeutic targets for ischemic stroke is indispensable. Approximately 50% of ischemic strokes are attributed to large-artery atherothrombotic disease, 25% to disease of the small intracranial arteries, 20% to cardiac emboli, and 5% to various rare causes (e.g., extracranial artery dissection) (4, 5) . The most common characteristic of acute ischemic stroke is an occlusion of the artery. Plaque composition is thought to be an independent risk factor for acute ischemic stroke (12) .
The thickness of the fibrous cap, the size of the necrotic core and intraplaque hemorrhage, and the extent of inflammatory activity within the plaque are key factors in advanced plaque that are most likely to lead to complications (13) . However, it was not possible to demonstrate how the complicated plaques associate with symptoms, since it appears that complicated plaques may occur at any time, irrespective of symptoms (14) . Additionally, the exact mechanisms causing plaque rupture remain to be determined (15) . Detection of vulnerable plaque is important for preventing future clinical events and remains to be resolved.
MicroRNAs (miRNAs or miRs) are non-coding RNAs that regulate gene expression by translation inhibition or messenger RNA degradation (16) . miRNAs that are highly stable in serum (17) and urine (18) are potential biomarkers of pathology, such as stroke (19, 20) and age-associated pathologies (21) . The differential expression of miRNAs in peripheral blood of young ischemic stroke patients in Malaysia has been previously examined (22) . However, the miRNAs involved in the formation and progression of atherosclerotic plaque have yet to be thoroughly investigated.
An intra-patient comparison on the transcript profile of atheromatous plaque and intact tissue samples was performed by Ayari and Bricca (23 the expression of CD163 and heme oxygenase (decycling) 1 (HMOX1), which are involved in the homeostasis of iron and heme in atherosclerotic plaques (23) .
In the present study, we aimed to identify which miRNAs were associated with the formation and progression of plaque, to investigate the potential mechanism of plaque vulnerability to rupture, and to examine potential biomarkers and therapeutic targets for acute ischemic stroke. The same microarray data as that used by Ayari and Bricca (23) were downloaded, and differentially expressed genes (DEGs) in paired atheromatous plaque and intact tissue samples were identified using the Multtest and Limma packages of R language. Enriched miRNAs that regulate the DEGs were then predicted using WebGestalt software. The expression of those predicted miRNAs in serum was confirmed using reverse transcription quantitative PCR (RT-qPCR). Protein-protein interactions (PPIs) of DEGs were constructed from STRING databases (http://string-db.org/), and confirmed miRNA-targeted DEGs interactions were visualized using Cytoscape software (http://www.cytoscape.org/). Gene ontology (GO) function and pathway analysis of confirmed miRNA-targeted DEGs were performed using the Bingo plug-in of Cytoscape software.
Materials and methods
Microarray data and data preprocessing. The gene microarray data GSE43292 (23) was downloaded from the Gene Expression Omnibus (GEO), which includes paired atheromatous plaque and intact tissue samples collected from 32 patients. Endarterectomy specimens were characterized histologically according to the classification proposed by the Nomenclature Committee of the American Heart Association (24) . The sections consisted of the intima and a majority of tunica media, although the tunica adventitia was excluded. Stage Ⅳ and later were considered as atheromatous plaques, and intact tissues were almost exclusively composed of stage I and Ⅱ lesions (23) . The platform of GSE43292 was GPL6244 (HuGene-1_0-st) Affymetrix Human Gene 1.0 ST Array [transcript (gene) version].
The mean expression of a total of 33,297 probes was derived from GEO, and accurate annotations were made. Probes matching >1 gene ID were discarded. All the probes were then mapped to Entrez gene IDs.
Screening of the DEGs. The log2 transformation of the expression value was performed for each probe (25) . Up-and down reg ulated probes were determined according to their fold differences (26) . DEGs were identified using the Multtest and Limma packages of R language (27) . The false discovery rate (FDR) correction was calculated using the Benjamini-Hochberg (BH) method (FDR < 0.05) (28) . A two-fold change method was used to identify DEGs (|log FC (Fold change)|> 1).
Prediction of enriched miRNAs in carotid atheroma. The WebGestal, a web-based gene set analysis toolkit, was used to predict miRNA associated with DEGs (29, 30) . The hypergeometric test was widely used to investigate the significance of functional terms enrichment within a list of genes. The 10 most significant categories (Top 10) and a minimum of two genes for a category were selected as the threshold. Patient samples and RNA isolation. Serum specimens were collected from 10 patients with acute ischemia stroke (average age of 69±10) and 10 healthy individuals (no disease) who received a health check-up. There were no significant differences in age and gender distributions between the patients with acute ischemic stroke and healthy controls (P>0.05). The acute ischemic stroke patients were associated with significant infract lesions. Serum samples prior to miRNA analysis were stored at -80˚C within 4 h following collection. The present study adhered to the tenets of the Declaration of Helsinki and was approved by the Medical Ethics Committee of Sichuan University (Sichuan, China). Informed consent was obtained from participants or their close relatives for the use of their blood in this study.
RT-qPCR. Total RNA was extracted from serum samples according to a method described previously (31) . Synthetic C. elegans miRNA (cel-miR-39; Qiagen, Hilden, Germany) was spiked in each extracted RNA at a final concentration of 4 fmol as an internal control. The concentration and quality of RNA were measured by UV absorbance at 260 and 280 nm (A260/280 ratio).
Ten nanograms of total RNA was reverse transcribed and qPCR was performed using an All-in-One™ miRNA qRT-PCR Detection kit (GeneCopoeia, Rockville, MD, USA) according to the manufacturer's instructions. The validated All-in-One miRNA forward primers were purchased from GeneCopoeia. Forward primers specific for cel-miR-39 were designed based on a sequence of mature miRNA obtained from the miRbase (32) . The levels of miRNAs were normalized with cel-miR-39. The 2 −ΔΔCT method, described by Livak et al (33) , was used to analyze data. miR-9 in each serum sample and no-template controls were run in triplicate.
Statistical analysis. Statistical analysis was performed using the two-tailed paired Student's t-test using IBM SPSS 21.0 (SPSS, Inc., Chicago, IL, USA). Differences were considered statistically significant at P<0.05.
Confirmed miRNA-targeted gene interaction network. PPIs of DEGs were constructed from the STRING databases (34) , and interactions associated with confirmed miRNAs were retained. miRNA-targeted DEGs interaction networks were visualized using the Cytoscape software version 3.1.1 (35) .
Hierarchical clustering of expressional values of DEGs.
Hierarchical clustering of expression data of the signature DEGs and the confirmed miRNA-targeted DEGs that were altered in atheromatous plaque was performed in a dChip Analyzer (36) . The clustering algorithms with Euclidean distance (37) metric and centroid linkage rule were used (36) .
GO function and pathway analysis of confirmed miRNAtargeted DEGs interaction. The Cytoscape software with plug-in Bingo was run to determine which biological processes are statistically overrepresented in the set of genes corresponding to the predicted miRNA-targeted DEGs interaction networks (38) . The hypergeometric test was employed with a BH-FDR-based multiple testing correction (corr P<0.01).
Results
Screening of the DEGs. The expression value was derived for each probe, and an accurate annotation was made. DEGs were identified using the Multtest and Limma packages of R language. In the present study, 56 and 69 genes that were significantly differentially down-and upregulated, respectively, were identified (data not shown).
Prediction of enriched miRNAs. The top 10 miRNAs significantly associated with the screened up-and downregulated DEGs were predicted using the WebGestalt toolkit (Table I) . Six miRNAs were connected with the upregulated DEGs including miR-9, -22, -23, -27, -125 and -524, and 10 miRNAs were connected with the downregulated DEGs including miR-9, -30, -33, -124, -135, -181, -197, -218, -330 and -452. A list of target DEGs associated with these miRNAs is provided in Table I . In the DEGs provided in Table Ⅱ , the expression of vav 3 guanine nucleotide exchange factor (VAV3) and PR domain containing 1 (PRDM1) was 2.0-fold higher than that in the intact tissue, and the expression of β-thyroid hormone receptor (THRB) and contactin 4 (CNTN4) in atheromatous plaque was a notable 2.1-and 3.5-fold lower than that in the intact tissue, respectively. Notably, miR-9 was associated with both down-and upregulated DEGs.
Validation of predicted serum miRNA in acute ischemic stroke. The expression of predicted serum miRNAs in acute ischemic stroke was validated by RT-qPCR (Fig. 1) . It was confirmed that the expression of serum miR-9, -30, -33, -124, -181, -218, -330, -22, -23 and -125 was significantly altered in ischemic stroke, indicating these miRNAs are important in acute ischemic stroke.
Confirmed miRNA-targeted DEGs interaction networks and important DEG nodes.
PPIs of DGEs were constructed from the STRING databases. Interactions associated with confirmed miRNAs were retained, and confirmed miRNA-targeted DEGs interaction networks were subsequently visualized using Cytoscape software (Fig. 2) . Four miRNAs were linked to 25 downregulated DEGs ( Fig. 2A ) and 7 miRNAs were linked to 28 upregulated DEGs (Fig. 2B) forming miRNAs-DEGs interaction networks. Table Ⅱ shows the DEGs in the interaction networks. The most important nodes in the miRNA interaction networks were downregulated DEGs including THRB, CNTN4, NEGR1 and glutamate receptor 2 (GRIA2) (Fig. 1A) , and upregulated DEGs including VAV3, PRDM1, CD163, matrix metallopeptidase 9 (MMP9), pleckstrin (PLEK), CD36, chemokine (C-X-C motif) ligand 10 (CXCL10), chemokine (C-C motif) receptor 1 (CCR1), regulator of G-protein signaling 1 (RGS1), HMOX1, tartrate resistant acid phosphatase 5 (ACP5), dipeptidyl peptidase 4 (DPP4) and selectin E (SELE) (Fig. 2B) .
Hierarchical clustering of expressional values of DEGs.
Using the algorithm based on Euclidean distance metric and centroid linkage rule, the hierarchical clustering of expressional values of DEGs and the confirmed miRNA-targeted DEGs were divided into the atheromatous plaque and intact tissue groups (Fig. 3) . Fig. 3 shows atheromatous plaque and intact tissue samples separated with the exception of 13 paired samples that were not well classified. There were 10 intact tissues clustered in the atheromatous plaque group, and three atheromatous plaques in the intact tissue group, indicating that the differences in gene expression between intact tissues and atheromatous plaques from those patients are extremely close and difficult to distinguish, and that there was a high risk of atheromatous in the 10 patients. Nevertheless, two clustering maps showed identical resampling, suggesting that the confirmed miRNA-targeted DEGs are important representative genes in the interaction networks, and that screening is extremely significant. confirmed miRNAs targeting downregulated DEGs were predominately associated with signal transduction, the circulatory system, biological adhesion and striated muscle contraction, and that the targeted upregulated DEGs were most significantly associated with signal transduction, wound healing and the immune system (Table Ⅲ) .
GO function and pathway analysis of confirmed miRNAtargeted DEG interaction. GO function suggested that the

Discussion
The predominant etiology of stroke is atherosclerosis (atheroma) (39) . The present study provides a list of potential clinical diagnoses and prognostic biomarkers and therapeutic targets for acute ischemic stroke via the identification of a list of DEGs associated with miRNA targets, the validation of expression of predicted miRNAs in acute ischemic stroke, and the GO function analysis of the confirmed miRNAs targeted DEGs in the advanced plaque using the microarray data from Ayari and Bricca (23) . Furthermore, a new molecular mechanism causing atherosclerotic plaque rupture and intraplaque hemorrhage, and subsequently ischemic stroke remains to be determined.
Whole-transcript expression profile of human atherosclerotic arteries (endarterectomy specimens) was performed by Ayari and Bricca (23) . As it is impossible to obtain normal artery tissue, the intra-patient comparison on the expression profile of atheromatous plaque and intact tissues from the individual was carried out to examine the atherogenic process per se (23). Ayari and Bricca analyzed the expression of two genes (CD163 and HMOX1) involved in the homeostasis of iron and heme, and their role in atheromatous plaques (23) .
In the present study, we identified 56 downregulated DEGs and 69 upregulated DEGs (including CD163 and HMOX1). A 2-fold change with FDR<0.05 was set as the threshold criterion. Using these DEGs, we screened the associated Top 10 miRNA. Six miRNAs were linked to the upregulated DEGs including miR-9, -22, -23, -27, -125 and -524, and 10 miRNAs were linked to the downreg ulated DEGs including miR-9, -30, -33, -124, -135, -181, -197, -218, -330 and -452 (Table I) . Of these miRNAs, miR-33 and miR-125 were found to associate with hyperlipidemia (19) . Notably, miR-9 is an important miRNA associated with down-and upregulated DEGs. The significant change in expression of predicted serum miRNAs (miR-9, -30, -33, -124, -181, -218, -330, -22, -23 and -125) in acute ischemic stroke was validated by RT-qPCR. The results confirmed that miRNAs may be important in acute ischemic stroke. PPIs of DGEs were constructed from the STRING databases, and any interactions that were not associated with any miRNA targets were discarded, such as the interaction between calponin 1 (CNN1) and myocardin (MYOCD), which played crucial roles in cardiogenesis and differentiation of the smooth muscle cell lineage (40) , as well as the interaction between tryptophan 2,3-dioxygenase (TDO2) and kynureninase (KYNU), which were involved in tryptophan metabolism (41) . Interactions associated with confirmed miRNAs were retained, and the confirmed miRNA-targeted DEGs interaction networks were constructed. In total, 25 downregulated DEGs and 28 upregulated DEGs were involved in the miRNAs-DEGs interaction networks.
In the present study, the intact tissues were type I and Ⅱ lesions, and the atheromatous plaque was type Ⅳ lesion and later lesion according to the definition and classification suggested by the Nomenclature Committee of the American Heart Association (24). Of note, type I and Ⅱ lesions may be combined under the term early lesions, and type Ⅳ-Ⅵ lesions combined under the term advanced lesions. The early lesions generally are those that occur in infants and children, although they also occur in adults (24) . Following the early lesions onset, advanced lesions may subsequently evolve following thickening of the arterial wall and therefore narrowing of the lumen or obstruction or modification of the blood flow. Thus, common gene expression in early and advanced lesions from some individuals may be identical. This hypothesis was supported by the hierarchical clustering maps which did not separate all the endarterectomy specimens into intact tissue and atheromatous plaque groups. Nevertheless, two clustering maps showed identical resampling, indicating that the miRNA-target DEGs were important representative genes in the interaction networks, and that screening is essential.
In the confirmed miRNAs-targeted DEGs interaction networks, the most important nodes identified were THRB, CNTN4, NEGR1 and GRIA2 in the downregulated network, and VAV3, PRDM1, CD163, MMP9, PLEK, CD36, CXCL10, CCR1, RGS1, HMOX1, ACP5, DPP4 and SELE in the upregulated network. Of note, the miR-9 target DEGs including THRB, CNTN4, NEGR1, VAV3 and PRDM1 were important nodes in the miRNAs-target DEGs interaction networks, suggesting that miR-9 plays a central role in the atheroma. The important nodes were enriched in the GO term.
Ischemic stroke occurs when an artery is obstructed (19) , which is most often caused by atheroma. Atheroma (atherosclerosis), which is also known as the type Ⅵ lesion, is characterized by larger, confluent and more disruptive core of extracellular lipid (24) . Almost 70% of plaque specimens (carotid endarterectomy specimens) demonstrated fissures, hematoma or hemorrhage, and/or thrombus, 64% demonstrated neovascularization (14, 24) . Arteries with thinned or ruptured fibrous caps, intraplaque hemorrhage, larger lipid-rich necrotic cores and larger wall thickness were associated with the occurrence of subsequent clinical events, especially the stroke (19, 42) . In addition, recurrent stroke is associated with a higher incidence of large-artery atherosclerosis than the first stroke (19) . The exact mechanisms causing plaque are not yet completely known (15) . The plaques that are rich in soft extracellular lipid (43) , neoformed vessels and inflammatory infiltration (44) are vulnerable. The fibrous cap at the site of the rupture/erosion had an eroded surface characterized by loss of the endothelial lining (45) . As demonstrated in GO annotations: CD36 was associated with lipid storage (GO: 19915); and HOMOX1, CCR1, SELE, CD163 and CXCL10 were associated with the inflammatory response (GO: 6950). miR-9 targeted downregulated DEGs including CNTN4, NEGR1 and THRB were predominately associated with biological adhesion and regulation of the neurological system, and targeted upregulated DEGs including VAV3 and PRDM1 were most significantly associated with signal transduction and vasculature development, showing a crucial role of miR-9 in the vulnerability of plaque. By contrast, the miRNA expression profile in young stroke patients (18-49 years) have not shown a difference in miR-9 (22) . Our results supported that miR-9 is a potential biomarker for acute ischemic stroke. We also observed significant changes in miR-30, -33, -124, -181, -218, -330, -22, -23 and -125 expression. However, further investigation focusing on their role in acute ischemic stroke should be conducted. Furthermore, investigation into the molecular mechanism underlying the formation and rupture of atherosclerotic plaque may provide a new therapeutic strategy for the prevention, diagnosis, treatment and prognosis of ischemic strokes.
